Literature DB >> 12670672

The treatment of complex regional pain syndrome type I with free radical scavengers: a randomized controlled study.

R S G M Perez1, W W A Zuurmond, P D Bezemer, D J Kuik, A C van Loenen, J J de Lange, A J Zuidhof.   

Abstract

To compare the effects of two free radical scavengers, dimethylsulfoxide 50% (DMSO) and N-acetylcysteine (NAC), for treatment of complex regional pain syndrome I (CRPS I), a randomized, double-dummy controlled, double-blind trial was conducted. Two outpatient clinics of two university hospitals in The Netherlands participated in the study and 146 patients, were included over a period of 24 months. Patients were randomized into two treatment groups, one was instructed to apply DMSO 50% five times daily to the affected extremity, the second was treated with NAC 600mg effervescent tablets three times daily, both combined with placebo. Interventions were accompanied by pain medication, occupational therapy for upper extremity CRPS I and physical therapy for lower extremity CRPS I in specific circumstances. Treatment was given for 17 weeks, with a possibility to continue or switch medication after this period, up to 1 year following the onset of treatment. An impairment level sum score was the primary outcome measure. Upper and lower extremity skills and functions, and general health status were also evaluated. Overall, no significant differences were found between NAC and DMSO after 17 and 52 weeks on impairment level and general health status. Significant differences were found for subscores of lower extremity function, in favor of DMSO-treatment. Subgroup analysis showed more favorable results for DMSO for warm CRPS I and significantly better performance of NAC for patients with a cold CRPS I. Results tended to be negatively influenced if the duration of the complaint was longer. Treatment with DMSO and NAC are generally equally effective in treatment of CRPS I. Strong indications exist for differences in effects for subgroups of patients with warm or cold CRPS I: for warm CRPS I, DMSO-treatment appears more favorable, while for cold CRPS I, NAC-treatment appears to be more effective.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12670672     DOI: 10.1016/s0304-3959(02)00414-1

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  48 in total

Review 1.  N-acetylcysteine -- passe-partout or much ado about nothing?

Authors:  Mirja-Liisa Aitio
Journal:  Br J Clin Pharmacol       Date:  2006-01       Impact factor: 4.335

2.  Improving the diagnosis and treatment of CRPS: insights from a clinical immunologist's personal experience with an underrecognized neuroinflammatory disorder.

Authors:  Karen E Binkley
Journal:  J Neuroimmune Pharmacol       Date:  2012-05-16       Impact factor: 4.147

3.  Applying salve in complex regional pain syndrome.

Authors:  Femke Bonte-Mineur; Annette Verzijl; Frank Huygen; Jan van Laar
Journal:  BMJ Case Rep       Date:  2009-05-21

4.  Direct intrawound administration of dimethylsulphoxide relieves acute pain in rats.

Authors:  Mayank Gautam; Pranav Prasoon; Rahul Kumar; Anurag Singh; Prawal Shrimal; Subrata B Ray
Journal:  Int Wound J       Date:  2014-04-21       Impact factor: 3.315

Review 5.  Management of patients with complex regional pain syndrome type I.

Authors:  D Gatti; M Rossini; S Adami
Journal:  Osteoporos Int       Date:  2016-02-29       Impact factor: 4.507

6.  [Complex regional pain syndrome (CRPS) : An update].

Authors:  V Dimova; F Birklein
Journal:  Anaesthesist       Date:  2019-02       Impact factor: 1.041

7.  N-Acetyl-l-Cysteine Attenuates Ischemia/Reperfusion Injury-Induced Allodynia and N-Methyl-d-Aspartate Receptor Activation in Rats.

Authors:  Kyung-Hwa Kwak; Dong Gun Lim; Woon Yi Baek
Journal:  Curr Ther Res Clin Exp       Date:  2011-10

8.  Evidence based guidelines for complex regional pain syndrome type 1.

Authors:  Roberto S Perez; Paul E Zollinger; Pieter U Dijkstra; Ilona L Thomassen-Hilgersom; Wouter W Zuurmond; Kitty Cj Rosenbrand; Jan H Geertzen
Journal:  BMC Neurol       Date:  2010-03-31       Impact factor: 2.474

9.  Comparison of fluoroscopically guided and blind corticosteroid injections for greater trochanteric pain syndrome: multicentre randomised controlled trial.

Authors:  Steven P Cohen; Scott A Strassels; Leslie Foster; John Marvel; Kayode Williams; Matthew Crooks; Andrew Gross; Connie Kurihara; Cuong Nguyen; Necia Williams
Journal:  BMJ       Date:  2009-04-14

Review 10.  Regulation of peripheral blood flow in complex regional pain syndrome: clinical implication for symptomatic relief and pain management.

Authors:  George Groeneweg; Frank J P M Huygen; Terence J Coderre; Freek J Zijlstra
Journal:  BMC Musculoskelet Disord       Date:  2009-09-23       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.